Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2796|283|2|110-120

ISSN： 0954-6820

Source： JOURNAL OF INTERNAL MEDICINE, Vol.283, Iss.2, 2018-02, pp. : 110-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 25, Iss. 1, 2018-01 ,pp. : 4-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

PD‐1 targeting in cancer immunotherapy

By  

CANCER, Vol. 119, Iss. 23, 2013-12 ,pp. : E1-E3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neural Blockade, Urokinase and Prostaglandin E1 Combination Therapy for Acute Digital Ischemia of Progressive Systemic Sclerosis

By  

THE JOURNAL OF DERMATOLOGY, Vol. 21, Iss. 10, 1994-10 ,pp. : 755-759

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti PD-1 and PDL-1 Immunotherapy in the Treatment of Advanced Non- Small Cell Lung Cancer (NSCLC): A Review on Toxicity Profile and its Management

By  

Current Drug Safety, Vol. 11, Iss. 1, 2016-03 ,pp. : 62-68

Bentham Science Publishers

Access to resources Recommend Favorite

Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 11, 2015-11 ,pp. : 789-794

John Wiley & Sons Inc

Access to resources Recommend Favorite